Who invested in Kano Therapeutics

2 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 12 months ago

Funding summaryUpdated 26 Oct 2026

$5.0Mraised across 2 rounds since 2024, from 2 sources

Latest round: VentureNov 2025
Biggest round: $5.0MSeed · Aug 2024
Investors: 5

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2025

$5.0MSeed?Venture

First round: Seed, $5.0M
Biggest round: $5.0M
Between rounds: 15 months

The rounds

Nov 2025
VentureAmount undisclosed1 new3 returning
Source recorded
Aug 2024
Seed$5.0M4 new
Source recordedSEC filing: $5.0M sold, first sale May 2024

Founders and team

From Kano Therapeutics's own website and the SEC filings it signed: 2 founders, 3 on the team.

Dr. Floris EngelhardtCEO/CSO & Co-FounderNamed on its 2024 Form D

John VroomChief Business Officer & Co-FounderNamed on its 2024 Form D

Christian BurnsAssociate Director, Platform
Dr. Seth EttenbergIndependent Board Member
Emma ColeResearch Associate

On the board, as filediAnn DeWitt

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Seed2024Venture2025

Everyone who backed them

MetaplanetVC firm2rounds

Taihill VentureVC firm2rounds

Engine VenturesVC firm2rounds

ZAKA VCVC firm1round

Vsquared VenturesVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Kano Therapeutics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.